サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1534273

遺伝子解析装置の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）

Global Genetic Analyzer Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 225 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
遺伝子解析装置の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 225 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子解析装置の市場規模は、2023年の117億5,000万米ドルから、2032年には244億4,000万米ドル近くに達し、調査期間2024年～2032年のCAGRは8.48%と推定されます。

遺伝子解析装置は、DNA配列決定、遺伝子型判定、遺伝子発現プロファイリングを含む遺伝子解析用の先進機器です。これらの機器により、研究者や臨床医は遺伝物質を分子レベルで調べることができ、遺伝的変異、突然変異、遺伝性疾患に関する洞察を得ることができます。これらの解析装置は、マイクロアレイ解析、ポリメラーゼ連鎖反応、次世代シーケンシング（NGS）など、さまざまな技術を使用して、正確で包括的な遺伝子データを提供します。この情報は、医療診断、個別化医療、遺伝子研究への応用に極めて重要です。病気や薬への反応に関連する遺伝子マーカーを特定することで、これらの解析装置は標的治療の開発をサポートし、ゲノミクスと個別化医療の進歩に貢献します。

市場力学

遺伝子解析装置市場は、個別化医療に対する需要の高まりとともに、遺伝性疾患や慢性疾患の有病率が高まっていることから急速に拡大しています。遺伝子解析装置は、遺伝子疾患の診断と理解に不可欠なツールを提供し、より正確で個別化された治療計画を可能にします。遺伝子解析技術の技術的進歩も市場成長の原動力となっています。次世代シーケンシング（NGS）やCRISPRベースの技術などの革新は、遺伝子解析の精度、スピード、拡張性を高めています。これらの進歩により、包括的なゲノムワイド調査や以前は検出できなかった遺伝子変異の同定が可能になり、研究や臨床応用が進展します。ゲノム研究と臨床診療への遺伝子データの統合が重視されるようになっていることも、市場機会の拡大に寄与しています。政府と研究機関はゲノミクス・イニシアチブに費用を投じており、遺伝子解析装置の導入に有利な環境を作り出しています。ゲノムデータベースやバイオバンクの拡大も、新規診断・治療アプローチの開発を後押ししています。家系やライフスタイルに関する洞察を含む、健康とウェルネスのための遺伝子検査に対する消費者の関心の高まりは、市場成長のさらなる機会をもたらしています。遺伝子情報の価値に対する一般の認識が高まるにつれ、利用しやすく信頼性の高い遺伝子解析ソリューションに対する需要が高まっています。しかし、高コストと複雑な規制要件が市場の成長を抑制する可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは遺伝子解析装置の世界市場における各セグメントを包括的に評価することもできます。遺伝子解析装置産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

遺伝子解析装置市場レポートのこのセクションでは、国別および地域別のセグメントに関する詳細なデータを提供し、それによって戦略担当者がそれぞれの製品またはサービスのターゲット層を特定する上で、今後のビジネスチャンスを支援します。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの地域展望をカバーし、遺伝子解析装置市場の現在と将来の需要を明らかにしています。さらに、すべての主要地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 遺伝子解析装置-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 遺伝子解析装置の世界市場分析：製品別

  • 製品別の概要
  • 製品別の実績・予測データ分析
  • 試薬・キット
  • 機器
  • ソフトウェア

第6章 遺伝子解析装置の世界市場分析：検査別

  • 検査別の概要
  • 検査別の実績・予測データ分析
  • 予測遺伝子検査
  • キャリア検査
  • 出生前・新生児検査
  • 疾患診断検査
  • 薬理ゲノム検査
  • その他

第7章 遺伝子解析装置の世界市場分析：用途別

  • 用途別の概要
  • 用途別の実績・予測データ分析
  • がん
  • 遺伝子疾患
  • 心血管疾患
  • 希少疾患
  • 感染症
  • その他

第8章 遺伝子解析装置の世界市場分析：技術別

  • 技術別の概要
  • 技術別の実績・予測データ分析
  • 次世代シーケンサー（NGS）
  • リアルタイムPCRシステム
  • その他

第9章 遺伝子解析装置の世界市場分析：最終用途別

  • 最終用途別概要
  • 最終用途別の実績・予測データ分析
  • 病院
  • 研究開発ラボ
  • 診断センター
  • その他

第10章 遺伝子解析装置の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第11章 遺伝子解析装置企業の競合情勢

  • 遺伝子解析装置市場の競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品発売
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • PerkinElmer Inc.
  • BioRad Laboratories
  • AutoGenomics Inc.
  • ELITech Group
  • IntegraGen
  • Quest Diagnostics Inc.
  • Hoffmann-La Roche AG
  • Celera Group
  • Qiagen
  • Danaher（Cepheid）
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Analysis By Test (USD MN)
  • Predictive Genetic Testing Market Sales By Geography (USD MN)
  • Carrier Testing Market Sales By Geography (USD MN)
  • Prenatal and Newborn Testing Market Sales By Geography (USD MN)
  • Disease Diagnostic Testing Market Sales By Geography (USD MN)
  • Pharmacogenomic Testing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Genetic Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Next-generation Sequencing (NGS) Market Sales By Geography (USD MN)
  • Real-Time PCR System Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Research & Development Laboratories Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Genetic Analyzer Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Genetic Analyzer Report
  • Market Research Process
  • Market Research Methodology
  • Global Genetic Analyzer Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Test
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Global Market Analysis By Test (USD MN)
  • Predictive Genetic Testing Market Sales By Geography (USD MN)
  • Carrier Testing Market Sales By Geography (USD MN)
  • Prenatal and Newborn Testing Market Sales By Geography (USD MN)
  • Disease Diagnostic Testing Market Sales By Geography (USD MN)
  • Pharmacogenomic Testing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Genetic Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Rare Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Next-generation Sequencing (NGS) Market Sales By Geography (USD MN)
  • Real-Time PCR System Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Research & Development Laboratories Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112115348

The global demand for Genetic Analyzer Market is presumed to reach the market size of nearly USD 24.44 Billion by 2032 from USD 11.75 Billion in 2023 with a CAGR of 8.48% under the study period 2024-2032.

Genetic analyzers are advanced instruments for genetic analyses, including DNA sequencing, genotyping, and gene expression profiling. These devices enable researchers and clinicians to examine genetic material at a molecular level, providing insights into genetic variations, mutations, and hereditary conditions. These analyzers use various technologies, such as microarray analysis, polymerase chain reaction, and next-generation sequencing (NGS), to deliver accurate and comprehensive genetic data. This information is crucial for applications in medical diagnostics, personalized medicine, and genetic research. By identifying genetic markers linked to diseases and response to medications, these analyzers support the development of targeted therapies and contribute to advancements in genomics and personalized healthcare.

MARKET DYNAMICS

The genetic analyzer market is expanding rapidly due to the escalating prevalence of genetic disorders and chronic diseases, together with the growing demand for personalized medicine. Genetic analyzers provide essential tools for diagnosing and understanding genetic conditions, enabling more precise and individualized treatment plans. Technological advancements in genetic analysis technologies are also driving market growth. Innovations such as next-generation sequencing (NGS) and CRISPR-based technologies enhance genetic analyses' accuracy, speed, and scalability. These advancements enable comprehensive genome-wide studies and the identification of previously undetectable genetic variants, advancing research and clinical applications. The growing emphasis on genomic research and the integration of genetic data into clinical practice further contribute to market opportunities. Governments & research institutions are spending on genomics initiatives, creating a favorable environment for adopting genetic analyzers. The expansion of genomic databases and biobanks also supports the development of novel diagnostic & therapeutic approaches. The rise in consumer interest in genetic testing for health and wellness, including ancestry and lifestyle insights, presents additional opportunities for market growth. As public awareness of genetic information's value increases, there is a growing demand for accessible and reliable genetic analysis solutions. However, high costs and complex regulatory requirements may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Genetic Analyzer. The growth and trends of Genetic Analyzer industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Genetic Analyzer market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Reagents & Kits
  • Instruments
  • Software

By Test

  • Predictive Genetic Testing
  • Carrier Testing
  • Prenatal and Newborn Testing
  • Disease Diagnostic Testing
  • Pharmacogenomic Testing
  • Others

By Application

  • Cancer
  • Genetic Diseases
  • Cardiovascular Diseases
  • Rare Diseases
  • Infectious Diseases
  • Others

By Technology

  • Next-generation Sequencing (NGS)
  • Real-Time PCR System
  • Others

By End-use

  • Hospitals
  • Research & Development Laboratories
  • Diagnostic Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Genetic Analyzer market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Genetic Analyzer market include Thermo Fisher Scientific, Abbott Laboratories, PerkinElmer Inc., BioRad Laboratories, AutoGenomics Inc., ELITech Group, IntegraGen, Quest Diagnostics Inc., Hoffmann-La Roche AG, Celera Group, Qiagen, Danaher (Cepheid). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. GENETIC ANALYZER - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Test
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Reagents & Kits Historic and Forecast Sales By Regions
  • 5.4. Instruments Historic and Forecast Sales By Regions
  • 5.5. Software Historic and Forecast Sales By Regions

6. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY TEST

  • 6.1. Overview By Test
  • 6.2. Historical and Forecast Data Analysis By Test
  • 6.3. Predictive Genetic Testing Historic and Forecast Sales By Regions
  • 6.4. Carrier Testing Historic and Forecast Sales By Regions
  • 6.5. Prenatal and Newborn Testing Historic and Forecast Sales By Regions
  • 6.6. Disease Diagnostic Testing Historic and Forecast Sales By Regions
  • 6.7. Pharmacogenomic Testing Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Cancer Historic and Forecast Sales By Regions
  • 7.4. Genetic Diseases Historic and Forecast Sales By Regions
  • 7.5. Cardiovascular Diseases Historic and Forecast Sales By Regions
  • 7.6. Rare Diseases Historic and Forecast Sales By Regions
  • 7.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY TECHNOLOGY

  • 8.1. Overview By Technology
  • 8.2. Historical and Forecast Data Analysis By Technology
  • 8.3. Next-generation Sequencing (NGS) Historic and Forecast Sales By Regions
  • 8.4. Real-Time PCR System Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-use
  • 9.2. Historical and Forecast Data Analysis By End-use
  • 9.3. Hospitals Historic and Forecast Sales By Regions
  • 9.4. Research & Development Laboratories Historic and Forecast Sales By Regions
  • 9.5. Diagnostic Centers Historic and Forecast Sales By Regions
  • 9.6. Others Historic and Forecast Sales By Regions

10. GLOBAL GENETIC ANALYZER MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE GENETIC ANALYZER COMPANIES

  • 11.1. Genetic Analyzer Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF GENETIC ANALYZER INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Thermo Fisher Scientific
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Abbott Laboratories
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. PerkinElmer Inc.
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. BioRad Laboratories
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. AutoGenomics Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. ELITech Group
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. IntegraGen
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Quest Diagnostics Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Hoffmann-La Roche AG
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Celera Group
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Qiagen
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. Danaher (Cepheid)
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies